drugset / Trial / NCT00715702
Safety Study of AZD5672 in Renally Impaired Subjects
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to investigate the pharmacokinetics of a single dose of AZD5672 in patients with renal impairment by comparing with healthy volunteers
Timeline
- Start
- 2008-07
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD5672 | Small molecule | 100 mg | Oral |